According to the scheme administered to these patients during treatment, the following was obtained: 201 patients received 5-fluorouracil, cyclophosphamide and doxorubicin FAC, 84 patients were treated with adriamycin and cyclophosphamide ACII, 30 patients were treated with cyclophosphamide, methotrexate and 5-fluorouacil CMF, and only three were treated with 5-fluorouracil plus methrotrexate 5FU + MTX.
De acuerdo con el esquema que recibieron estas pacientes durante su tratamiento, se obtuvo lo siguiente: 206 pacientes recibieron 5-fluoracilo, ciclofosfamida y doxorrubicina FAC; 84 fueron tratadas con adriamicina y ciclofosfamida ACII; 30 se sometieron a la ciclofosfamida, metotrexato y 5-fluoracilo CMF. Sólo tres pacientes recibieron 5-fluoracilo más metotrexato 5FU + MTX.